These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 24548204

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases.
    Tsagalis G, Psimenou E, Iliadis A, Nakopoulou L, Laggouranis A.
    Am J Kidney Dis; 2009 Aug; 54(2):340-4. PubMed ID: 19303679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
    Shishido S, Satou H, Muramatsu M, Hamasaki Y, Ishikura K, Hataya H, Honda M, Asanuma H, Aikawa A.
    Clin Transplant; 2013 Aug; 27(2):E143-50. PubMed ID: 23383697
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of focal segmental glomerulosclerosis.
    Ponticelli CE, Glassock RJ.
    Kidney Int; 2010 Feb; 77(3):259; author reply 259. PubMed ID: 20075961
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Focal sclerosing glomerulonephritis.
    Habib R, Gubler MC.
    Perspect Nephrol Hypertens; 1973 Feb; 1 Pt 1():263-78. PubMed ID: 4536428
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dilemma of focal segmental glomerular sclerosis.
    Cortes L, Tejani A.
    Kidney Int Suppl; 1996 Jan; 53():S57-63. PubMed ID: 8770992
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive therapy of primary focal sclerosing glomerulonephritis in the adult: a systematic review].
    Quereda C, Ballarín J, Galeano C, García López F, Praga M.
    Nefrologia; 2007 Jan; 27(3):249-60. PubMed ID: 17725445
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Rituximab for primary focal segmental glomerulosclerosis].
    Huang JN, Ren H.
    Zhonghua Nei Ke Za Zhi; 2017 Mar 01; 56(3):221-224. PubMed ID: 28253608
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
    Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C.
    Clin Nephrol; 1991 Aug 01; 36(2):53-9. PubMed ID: 1934660
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2006 Aug 01; 104(2):c75-82. PubMed ID: 16785738
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.